April 22, 2026
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today an update related to: Femasys Launches FemaSeed Complete for OB/GYNs at ACOG 2026.
